You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

intravenous immunoglobulin naïve (IVIG-naïve)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immunodeficiency Disease Trial in United States (Kedrion IVIG 10%)

Completed
Has Results
  • Primary Immunodeficiency Disease
  • Kedrion IVIG 10%
  • North Palm Beach, Florida
  • +10 more
Jan 26, 2022

Glycogen Storage Disease Type II Trial in Worldwide (avalglucosidase alfa)

Recruiting
  • Glycogen Storage Disease Type II
  • avalglucosidase alfa
  • Leuven, Belgium
  • +7 more
Jul 13, 2022

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Atlanta (VitalStim 400, VitalStim400)

Recruiting
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • VitalStim 400
  • VitalStim400
  • Atlanta, Georgia
    Center for Advanced Pediatrics, Children's Healthcare of Atlanta
Sep 2, 2022

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy Trial in Denmark (Immunoglobulin)

Recruiting
  • CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
  • Immunoglobulin
  • Aalborg, Denmark
  • +3 more
Oct 9, 2020

Primary Immunodeficiency Trial in United States (IGSC 20%)

Completed
  • Primary Immunodeficiency
  • IGSC 20%
  • Birmingham, Alabama
  • +11 more
Nov 2, 2022

Habitual Abortion, Recurrent Pregnancy Loss, Fertility Disorders Trial in Aalborg (Human Intravenous Immunoglobulins, (Privigen

Recruiting
  • Habitual Abortion
  • +3 more
  • Human Intravenous Immunoglobulins, (Privigen (R), CLS Behring)
  • +3 more
  • Aalborg, Denmark
    • The Centre for Recurrent Pregnancy Loss of Western Denmark, De
Jul 17, 2021

Kidney Transplantation Trial in Prague (Privigen, Thymoglobulin, Plasma Exchange)

Recruiting
  • Kidney Transplantation
  • Prague, Czechia
    Institute for Clinical and Experimental Medicine
Apr 3, 2021

Toxic Shock Syndrome Trial in Bron (Intravenous human immunoglobulin, Albumin)

Completed
  • Toxic Shock Syndrome
  • Intravenous human immunoglobulin
  • Albumin
  • Bron, France
    Hôpital Femme Mère Enfant
Jun 7, 2021

5% Treatment Naïve Intravenous Immunoglobulin Primary

Completed
  • Primary Immunodeficiency Disease (PIDD)
    • Newport Beach, California
    • +3 more
    Aug 6, 2019

    Primary Immunodeficiency Disease Trial in Hungary, Italy, Slovakia (Kedrion IVIG 10%)

    Recruiting
    • Primary Immunodeficiency Disease
    • Kedrion IVIG 10%
    • Budapest, Hungary
    • +8 more
    Jun 21, 2021

    Kawasaki Disease Trial in Shanghai (IVIG, Aspirin, Infliximab)

    Withdrawn
    • Kawasaki Disease
    • Shanghai, China
    • +4 more
    Mar 10, 2021

    Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome Trial in Amsterdam (Immune Globulin Intravenous

    Recruiting
    • Inflammatory Myopathy, Idiopathic
    • +5 more
    • Immune Globulin Intravenous (Human)
    • Placebo
    • Amsterdam, North- Holland, Netherlands
      Department of Neurology, Amsterdam UMC, location AMC
    Apr 14, 2023

    COVID-19 Trial in Karachi (SARS-CoV-2 antibody based IVIG therapy)

    Completed
    • COVID-19
    • SARS-CoV-2 antibody based IVIG therapy
    • Karachi, Sindh, Pakistan
      Dow University of Health Sciences
    Mar 21, 2021

    Small Fiber Neuropathy, Idiopathic Peripheral Neuropathy Trial in Boston (Intravenous immunoglobulin, 0.9% Sodium Chloride)

    Active, not recruiting
    • Small Fiber Neuropathy
    • Idiopathic Peripheral Neuropathy
    • Intravenous immunoglobulin
    • 0.9% Sodium Chloride
    • Boston, Massachusetts
      Beth Israel Deaconness Medical Center
    Apr 16, 2021

    Clinical Prognosis and Progression of Myasthenia Gravis Patients

    Recruiting
    • Myasthenia Gravis
    • Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)
    • Beijing, Beijing, China
      Xuan Wu Hospital, Capital Medical University
    Aug 19, 2021

    Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8 Trial in San Francisco (Angiogram,

    Recruiting
    • Prostate Adenocarcinoma
    • +9 more
    • Angiogram
    • +3 more
    • San Francisco, California
      University of California San Francisco
    Aug 5, 2022

    Primary Disease Trial in Jerusalem (VPRIV)

    Completed
    • Primary Disease
    • Jerusalem, Please Select..., Israel
      Michal Becker- Cohen
    Mar 18, 2021

    Guillain-Barré Syndrome Trial (Crovalimab, Placebo, Intravenous immunoglobulin therapy)

    Not yet recruiting
    • Guillain-Barré Syndrome
    • (no location specified)
    Aug 8, 2022

    Primary Immunodeficiency Trial in Assiut (minipooled- Intravenous immunoglobulin(MP-IVIG))

    Completed
    • Primary Immunodeficiency
    • minipooled- Intravenous immunoglobulin(MP-IVIG)
    • Assiut, Egypt
      Faculty of Medicine
    May 10, 2020

    Kidney Transplant Rejection Trial in Aurora (Tacrolimus Extended Release Oral Tablet [Envarsus], Plasma Exchange and IVIG

    Terminated
    • Kidney Transplant Rejection
    • Tacrolimus Extended Release Oral Tablet [Envarsus]
    • Plasma Exchange and IVIG (Intravenous Immunoglobulin )
    • Aurora, Colorado
      University of Colorado Anschutz Medical Campus
    Oct 23, 2020

    Myasthenia Gravis Trial in Toronto (subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin + subcutaneous immunoglobulin

    Recruiting
    • Myasthenia Gravis
    • subcutaneous immunoglobulin (SCIG)
    • intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
    • Toronto, Ontario, Canada
      University Health Network
    Nov 21, 2022

    Lymphoma Trial in Seattle (biological, other, procedure)

    Not yet recruiting
    • Lymphoma
    • Immune Globulin Infusion (Human), 10% Solution
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 21, 2023

    Kidney Transplantation in Highly Sensitized Patients Trial in United States (drug, procedure, other)

    Recruiting
    • Kidney Transplantation in Highly Sensitized Patients
    • Birmingham, Alabama
    • +12 more
    Jan 12, 2023

    Transplant Rejection Trial in Worldwide (BIVV020, Intravenous immunoglobulin (IVIg), Rituximab)

    Recruiting
    • Transplant Rejection
    • Westmead, New South Wales, Australia
    • +14 more
    Aug 2, 2022

    Mucocutaneous Lymph Node Syndrome Trial in United States (IVIG, Infliximab)

    Completed
    Has Results
    • Mucocutaneous Lymph Node Syndrome
    • Birmingham, Alabama
    • +28 more
    Nov 5, 2021